Role of the Calcium-Sensing Receptor in Reducing the Risk for Calcium Stones

被引:18
作者
Renkema, Kirsten Y. [1 ,2 ]
Bindels, Rene J. M. [1 ]
Hoenderop, Joost G. J. [1 ]
机构
[1] RUNMC, Dept Physiol, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands
[2] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2011年 / 6卷 / 08期
关键词
VITAMIN-D-RECEPTOR; FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; NEONATAL SEVERE HYPERPARATHYROIDISM; BONE-MINERAL DENSITY; CA2+-SENSING RECEPTOR; URINARY ACIDIFICATION; GENE POLYMORPHISMS; CA2+ REABSORPTION; DIVALENT-CATIONS; TRPV5; CHANNEL;
D O I
10.2215/CJN.00480111
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The tight control of blood Ca(2+) levels within a narrow range is essential for the performance of vital physiologic functions. Muscle contraction, neuronal excitation, and intracellular signaling processes acquisitively require Ca(2+). It is the concerted action of intestine, bone, and kidney that controls the Ca(2+) balance through the regulation of intestinal absorption, bone (de)mineralization, and renal excretion of Ca(2+), respectively. Along the nephron, fine-tuning of blood Ca(2+) levels takes place by Ca(2+) reabsorption. The calciotropic hormones regulate Ca(2+) transport processes, leading to whole-body Ca(2+) homeostasis and, importantly, preserving a constant Ca(2+) concentration in the blood. Defects in renal Ca(2+) handling can lead to hypercalciuria, consecutive kidney stone formation, and obstructive nephropathy. Here we give an overview of the key players involved in normal Ca(2+) management and describe the in-depth investigations on a renal hypercalciuric model of disease, the Trpv5 knockout mouse, which naturally displays molecular adaptations that prevent Ca(2+) precipitation in the kidney. Clin J Am Soc Nephrol 6: 2076-2082, 2011. doi: 10.2215/CJN.00480111
引用
收藏
页码:2076 / 2082
页数:7
相关论文
共 58 条
[1]   URINE COMPOSITION AND STONE FORMATION DURING TREATMENT WITH ACETAZOLAMIDE [J].
AHLSTRAND, C ;
TISELIUS, HG .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1987, 21 (03) :225-228
[2]   TRPV6 exhibits unusual patterns of polymorphism and divergence in worldwide populations [J].
Akey, Joshua M. ;
Swanson, Willie J. ;
Madeoy, Jennifer ;
Eberle, Michael ;
Shriver, Mark D. .
HUMAN MOLECULAR GENETICS, 2006, 15 (13) :2106-2113
[3]   CLONING AND CHARACTERIZATION OF AN EXTRACELLULAR CA2+-SENSING RECEPTOR FROM BOVINE PARATHYROID [J].
BROWN, EM ;
GAMBA, G ;
RICCARDI, D ;
LOMBARDI, M ;
BUTTERS, R ;
KIFOR, O ;
SUN, A ;
HEDIGER, MA ;
LYTTON, J ;
HEBERT, SC .
NATURE, 1993, 366 (6455) :575-580
[4]   NEPHROLITHIASIS IN RENAL TUBULAR-ACIDOSIS [J].
BUCKALEW, VM .
JOURNAL OF UROLOGY, 1989, 141 (03) :731-737
[5]   Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1 [J].
Cha, Seung-Kuy ;
Ortega, Bernardo ;
Kurosu, Hiroshi ;
Rosenblatt, Kevin P. ;
Kuro-O, Makoto ;
Huang, Chou-Long .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (28) :9805-9810
[6]   The β-glucuronidase klotho hydrolyzes and activates the TRPV5 channel [J].
Chang, Q ;
Hoefs, S ;
van der Kemp, AW ;
Topala, CN ;
Bindels, RJ ;
Hoenderop, JG .
SCIENCE, 2005, 310 (5747) :490-493
[7]   ECONOMIC-IMPACT OF UROLITHIASIS IN THE UNITED-STATES [J].
CLARK, JY ;
THOMPSON, IM ;
OPTENBERG, SA .
JOURNAL OF UROLOGY, 1995, 154 (06) :2020-2024
[8]  
COE FI, 1991, SEMIN NEPHROL, V11, P98
[9]   Kidney stone disease [J].
Coe, FL ;
Evan, A ;
Worcester, E .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (10) :2598-2608
[10]   Targeted inactivation of the 25-hydroxyvitamin D3-1α-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets [J].
Dardenne, O ;
Prud'homme, J ;
Arabian, A ;
Glorieux, FH ;
St-Arnaud, R .
ENDOCRINOLOGY, 2001, 142 (07) :3135-3141